BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Compugen

Compugen is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery, therapeutic and diagnostic. Compugen provides innovative products and services to pharmaceutical, biotechnology and other life science organizations through corporate solutions and to individual life scientists through the LabOnWeb.com Web site. In addition, the company is commercializing the genes and proteins that are discovered through the company's drug discovery division.


Contact Details:
7 Center Drive, Suite 7
Jamesburg
NJ
08831
United States of America
Tel:609 655 5105
Fax:609 655 5114
Email:info@cgen.com
WWW:

www.cgen.com




Loading...

Recent Publications by Compugen:

A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
PURPOSE: The Met receptor tyrosine kinase and its ligand, hepatocyte...
17th September, 2008
Compugen Clin Cancer Res. 2008 Jul 15;14(14):4612-21.
DOI Direct Link
Optimal data collection for correlated mutation analysis.
The main objective of correlated mutation analysis (CMA) is to predict...
26th July, 2008
Compugen LTD, Tel Aviv 69512, Israel. Proteins. 2008 Jul 24.
DOI Direct Link
Predicting proteolytic sites in extracellular proteins: only halfway there.
MOTIVATION: Many secretory proteins are synthesized as inactive precursors...
15th May, 2008
Compugen Ltd, 72 Bioinformatics. 2008 Apr 15;24(8):1049-55. Epub 2008 Mar 4.
DOI Direct Link
Presynaptic autoreceptors regulating transmitter release.
The discovery that the cytoplasmic membrane of presynaptic nerve terminals...
6th May, 2008
Alpha-2 Pharmaceutica AB, 8 Rosemblum Street, Apt. 4650, Tel Aviv 69379, Neurochem Int. 2008 Jan;52(1-2):26-30. Epub 2007 May 16.
DOI Direct Link
Compugen, Ltd.
Compugen's mission is to be the world leader in the discovery and...
26th April, 2008
Compugen Ltd, 72 Pinchas Rosen, Tel Aviv 69512, Israel. Pharmacogenomics. 2007 Oct;8(10):1461-3.
DOI Direct Link

View more Compugen research publications.

BioNews Results for Compugen:

Compugen discovers second peptide drug candidate for cancer treatment
Datamonitor:  Sep 18 2008 1:40AM Matching: compugen
CGEN: Discovers Peptide Drug Candidate for Treatment of Solid Tumor Cancers
Therapeutics Daily:  Sep 17 2008 3:42AM Matching: compugen
Compugen peptide may increase Taxol effectiveness: The peptide may also be effective in slowing the growth of
Therapeutics Daily:  Sep 17 2008 9:19PM Matching: compugen
Compugen Discovers Second Peptide Drug Candidate for Cancer Treatment
Red Orbit:  Sep 17 2008 8:10PM Matching: compugen
Compugen discovers second peptide drug candidate for cancer treatment
Therapeutics Daily:  Sep 17 2008 6:53PM Matching: compugen
Promote your company here: BioNewsCast - Press Release Distribution

View more Compugen news.

Compugen Patents:

US Patent No.Title
7368548 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer
7345142 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
7332569 Brain natriuretic peptide spliced variant
6936450 Variants of protein kinases
6783954 VEGF nucleic acid and amino acid sequences

View more Compugen patents.

Compugen (CGEN) Financial information Links from Barchart

CGEN Quote from from Barchart.com
CGEN Chart from from Barchart.com
CGEN Profile from from Barchart.com
CGEN Opinion from from Barchart.com

View more Compugen finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 270 times since April 2007, the link to the organisation's website has been followed 53 times

Recent Search Terms used to find this page: compugen | compugen | .

Search for more companies in Jamesburg

Search for more companies in NJ



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Compugen
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.